2024 Pitchers

Home » 2024 Pitchers

Start-up Slams

The Award for the most Innovative Start-up goes to:

V4CURE

The Start-up Slams were won by V4CURE, represented by Sonia Escaich, in the Metabolic diseases category.

They pitched at BioFIT 2024:

Tuesday, December 3^rd | 9.45 – 10.45 am

DIAGNOSTIC

FLUONIR
NIR-II Fluorescence | Fluorescence-Guided Surgery | Cancer Diagnosis and Treatment

BeLiver
Liver Cancer | Treatment Prediction | MedTech

Damocles Diagnostics
Rapid Diagnostics | Antibiotic Resistance | Point of Care

METABOLIC DISEASES

V4CURE
Drug | Aquaretic | Cardio-renal pathologies

Tuesday, December 3^rd | 2.00 – 3.45 pm

ONCOLOGY

Hemerion Therapeutics
Oncology | Neurology | Drug-Device Combo

CasInvent Pharma
Resistance in Cancer | New Mechanism to Fight Resist | AML – Venetovclax, PDAC Chemo

PepKon
Peptides | Oncology | First in Class

Starkage Therapeutics
Senescence | Oncology | ADC

Actipulse Neuroscience
Blood-Brain Barrier | Non-Invasive Neuromodulation | CNS Drug Delivery

Simmunext Biotherapeutics
Immunofilaments | Immunotherapy for Cancer | Bioconjugate

GlycoTherapeutics
Oncology | Glycobiology | Small Molecule

Wednesday, December 4^th | 9.45 – 10.45 am

CNS

InBrain Pharma
Dopamine Based DAT | Device Aided Therapy | Advanced Parkinson Disease

IPCURE
Dementia | Drug Development | Small Peptidomimetics

CELL & GENE THERAPY

ABLEVIA
Anti-Drug Antibody Removal | Orphan Diseases | Gene Therapy Vectors

Wednesday, December 4^th | 2.00 – 3.00 pm

ENABLING TECHNOLOGIES

IRUBIS
Bioprocessing | Spectroscopy | Process Analytical Technology

BiomimX
Mechanical Stimulation | 3D Human Tissues | Drug Safety/Efficacy

Biotactical
Sterility Testing | Bioluminescence | ATMP

GoodBot
Lab Automation | Liquid Handling | Pipetting Robot

Collaborative and licensing opportunity presentations

The Award for the most Promising Technology goes to:

BRENUS PHARMA

The most promising technology award went to Brenus Pharma, represented by Paul Bravetti.

They pitched at BioFIT 2024:

Tuesday, December 3^rd | 11.00 am – 12.30 pm

DIAGNOSTIC

Panadea Diagnostics
Antibody test | Highly specific | Multi-species

Biogem
Biosensor | Oncology | Diagnosis

IMMUNOLOGY

Institut Pasteur
Human Immune Response | 1,000-person cohort | Personalized Medicine

Lutech – Allergimmune
Adjuvant | Allergy | Immunotherapy

ONCOLOGY – DRUG DISCOVERY

European Institute of Oncology (IEO) – EPIKIN
Clinical Kinase Inhibitors | Unbiased Functional Profiling | High-throughput platform

ONCOLOGY

Brenus Pharma
Precision immuno-oncology | Active proteomic immunotherapies | Deep-tech biotechnology

Wednesday, December 4^th | 11.00 am – 12.30 pm

CELL & GENE THERAPY

Fondazione Telethon – THE FUTURE OF GENE THERAPY
Gene editing | Mobilisation conditioning | HSPC

IRCCS Ospedale Galeazzi – PCART-PROGENITOR CARTILAGE CELLS
Osteoarthritis | Regenerative Medicine | Cartilage

bespark*bio
Gene therapy | Enabling Technology | Viral Vector

CNS

Okinawa Institute
Alzheimer | Peptide drug | Tau

SATT Linksium – ASTROPROTECT
Alzheimer Disease | Neuroprotection | TRPA1

SATT AxLR – WOLTHER
Wolfram Syndrome | Alzheimer Disease | Sigma-1 agonists

DRUG DISCOVERY

Nebula
Generative AI | Drug targets discovery | Protein dynamics

Animal Health Presentations

The Award for the most Innovative Animal Health Project goes to:

BENNO THERAPEUTICS

Annelies Bogaerts, with her project Benno Therapeutics, is the winner of this year’s edition of the Animal Health Presentations.

The Animal Health Presentations focus on innovations in relation to animal well-being and health.

Co-organised by:

They pitched at BioFIT 2024:

Tuesday, December 3^rd | 4.15 – 5.00 pm

ANIMAL HEALTH

BENNO THERAPEUTICS
Vaccine | Canine cancer | Tumor vasculature

DAMOCLES DIAGNOSTICS – DAMAST
Point of Care | Diagnostic test | Fast AST

FINDIMMUNE – WOOF
Oral melanoma | Squamous cell carcinoma | Immunotherapy

INRAE TRANSFERT
SVCV | Vaccine platform | Host-pathogen model

Tuesday, December 3^rd | 5.15 – 6.00 pm

INRAE TRANSFERT
Influenza A virus | Vaccine | H5N1

GHENT UNIVERSITY
Bacterial infections | Antibiotic resistance | Pyoderma

VAXINANO
Nasal vaccines | Delivery system | Platform

AIHERD
Dairy | Monitoring | Detection

Farzad Abdi-Dezfuli, Partner, Sarsia
Jürgen Bauer, Deputy Managing Director, EMBLEM Technology Transfer
Gary Breit, CEO, Breit Ideas
Jean-Luc Chagnaud, Head of Business Development in Health Innovations, Aquitaine Science Transfert
Florence Dal Degan, Senior Director External Innovation, Rare Diseases and Neuroscience, Ipsen
Shobhit Dhawan, Fund Manager, Oncode Bridge Fund
Marie Duranteau, Associate, Program Manager, Sofinnova Partners
Guy Hélin, CEO, Syngulon
Frank Hensel, Principal, High-Tech Gründerfonds
Esther Lange, Industry Liaison Manager, Ascenion
Chloé Leprêtre, Head of Global R&D Search and Evaluation, Servier
Jérôme Majoie, General Manager, Fournier-Majoie Foundation
Eduardo Salas, Head of Technology Transfer and Business Development, IBEC
Corinne Szilagyi, Senior Partner, Member of the Business Development Committee, Biotech
Développement Conseils, France Biotech
Joachim Vogt, Director, Search and Evaluation, International, Abbvie
Anela Vukoja, COO, Apollo Health Ventures
Jean-Pascal Marc, General Manager, Ceanothus Consulting
Steve Nanchen, Senior Director – Head External Innovation, Elanco Animal Health
Edouardo De Oliveira Pontes, Associate Director Research Alliances – External Innovation,
Zoetis
Hervé Poulet, Director, Strategic Partnering, Boehringer Ingelheim Animal Health
Edouard Timsit, Director of Global Innovation Livestock Health and Sustainability, Ceva
Animal Health